The use of epoetin alfa in chemotherapy patients: A consistent profile of efficacy and safety

被引：11

作者：

Itri, LM ^{[1
]}

机构：

[1] Genta Inc, Clin Res & Dev, Berkeley Hts, NJ 07922 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.33539

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：81 / 87

页数：7

共 11 条

[1] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF THE ANEMIA OF CANCER [J].

ABELS, RI .

ACTA HAEMATOLOGICA, 1992, 87 :4-11

[2]

Cella D, 1998, SEMIN ONCOL, V25, P43

[3] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[4]

Dunphy FR, 1997, CANCER, V79, P1623, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1623::AID-CNCR28>3.3.CO

[5]

2-P

[6] Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing [J].

Gabrilove, JL ;

Cleeland, CS ;

Livingston, RB ;

Sarokhan, B ;

Winer, E ;

Einhorn, LH .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2875-2882

[7] Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice [J].

Glaspy, J ;

Bukowski, R ;

Steinberg, D ;

Taylor, C ;

Tchekmedyian, S ;

VadhanRaj, S .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1218-1234

[8]

HENRY DH, 1994, SEMIN ONCOL, V21, P21

[9]

LEITGEB C, 1994, CANCER-AM CANCER SOC, V73, P2535, DOI 10.1002/1097-0142(19940515)73:10<2535::AID-CNCR2820731014>3.0.CO

[10]

2-5

← 1 2 →